Monte Rosa Therapeutics
Price & Volume
Stats
See more52W Range | $3.50-$25.77 |
Market Cap | $1.6B |
Shares Short | 7M |
Financials
See moreRevenue (12 Mos) | $181.5M |
Revenue Growth (YoY) | 38.5% |
Gross Profit (12 Mos) | $50.9M |
Diluted EPS | $0.32 |
News
See moreYahoo Finance • 2 months ago
Monte Rosa Therapeutics Presents Preclinical Data at AHA Scientific Sessions 2025 on the Potential of MRT-8102, a NEK7-directed Molecular Glue Degrader, to Treat Cardiovascular and Cardiometabolic Diseases
Yahoo Finance • 2 months ago
Monte Rosa Therapeutics Announces Third Quarter 2025 Financial Results and Business Updates
Yahoo Finance • 2 months ago
Monte Rosa Therapeutics to Participate in Upcoming Investor Conferences
About
CEO | Dr. Markus Warmuth M.D. |
Address | 321 Harrison Avenue, Boston, MA, United States, 02118 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 147 |
